ESR1 and breast cancer: Recent studies have found that androgen receptor (AR) is highly expressed in ER-/Her2+ breast tumors and androgens and AR stimulate the growth of ER−/Her2+ breast cancer cells by activating oncogenic Wnt signaling pathways [2].